Artificial intelligence–enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial
Top Cited Papers
- 6 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (5), 815-819
- https://doi.org/10.1038/s41591-021-01335-4
Abstract
We have conducted a pragmatic clinical trial aimed to assess whether an electrocardiogram (ECG)-based, artificial intelligence (AI)-powered clinical decision support tool enables early diagnosis of low ejection fraction (EF), a condition that is underdiagnosed but treatable. In this trial (NCT04000087), 120 primary care teams from 45 clinics or hospitals were cluster-randomized to either the intervention arm (access to AI results; 181 clinicians) or the control arm (usual care; 177 clinicians). ECGs were obtained as part of routine care from a total of 22,641 adults (N = 11,573 intervention; N = 11,068 control) without prior heart failure. The primary outcome was a new diagnosis of low EF (≤50%) within 90 days of the ECG. The trial met the prespecified primary endpoint, demonstrating that the intervention increased the diagnosis of low EF in the overall cohort (1.6% in the control arm versus 2.1% in the intervention arm, odds ratio (OR) 1.32 (1.01–1.61), P = 0.007) and among those who were identified as having a high likelihood of low EF (that is, positive AI-ECG, 6% of the overall cohort) (14.5% in the control arm versus 19.5% in the intervention arm, OR 1.43 (1.08–1.91), P = 0.01). In the overall cohort, echocardiogram utilization was similar between the two arms (18.2% control versus 19.2% intervention, P = 0.17); for patients with positive AI-ECGs, more echocardiograms were obtained in the intervention compared to the control arm (38.1% control versus 49.6% intervention, P < 0.001). These results indicate that use of an AI algorithm based on ECGs can enable the early diagnosis of low EF in patients in the setting of routine primary care.Keywords
Funding Information
- Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
This publication has 24 references indexed in Scilit:
- 2013 ACCF/AHA Guideline for the Management of Heart FailureJournal of Invasive Cardiology, 2013
- Screening for Asymptomatic Left Ventricular Dysfunction Using B‐Type Natriuretic PeptideCongestive Heart Failure, 2008
- Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the CommunityJournal of the American College of Cardiology, 2003
- The Epidemiology of “Asymptomatic” Left Ventricular Systolic Dysfunction: Implications for ScreeningAnnals of Internal Medicine, 2003
- Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up studyThe Lancet, 2003
- Burden of Systolic and Diastolic Ventricular Dysfunction in the CommunityJAMA, 2003
- Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the communityHeart, 2000
- Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional surveyBMJ, 1999
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationThe Lancet, 1997
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsThe New England Journal of Medicine, 1992